US EditionLarge Oncosomes in the Blood May Enable Cancer Diagnosis and Monitoring
3 Articles
3 Articles
Large oncosomes in the blood may enable cancer diagnosis and monitoring
Cedars-Sinai investigators have discovered that large oncosomes—fluid-filled sacs released into the bloodstream by aggressive cancer cells—contain a consistent set of molecules across cancer types. Their findings, published in Cell Reports Medicine, highlight large oncosomes in the blood as a possible method of diagnosing and monitoring malignancies.
The success of REACTION could transform the clinical management of childhood leukemia, placing prevention as the central axis of the therapeutic strategy. In addition, the project lays the foundation for the development of new epigenetic therapies and the personalization of treatment according to the individual risk of each patient. Acute lymphoblastic B-cell leukemia is the most frequent pediatric cancer and, although current treatments have si…
Pan-Cancer Blood Test Breakthrough - BioPatrika
Pan-Cancer Blood Test Breakthrough: Plasma Proteins Show Promise for Early Cancer Detection and Monitoring BioPatrika – In a landmark study that could revolutionize cancer diagnosis, scientists have identified a wealth of potential cancer biomarkers in the blood, paving the way for a single blood test to detect multiple types of cancer at an early stage. […] The post Pan-Cancer Blood Test Breakthrough appeared first on BioPatrika.
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
